Vitrolife AB (FRA:VTFN) YoY EBITDA Growth : 20.34% (As of Jun. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vitrolife AB's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 20.34%.

Vitrolife AB's EBITDA per Share for the three months ended in Jun. 2024 was €0.14.

Vitrolife AB YoY EBITDA Growth Historical Data

The historical data trend for Vitrolife AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB YoY EBITDA Growth Chart

Vitrolife AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

20.28

-21.46

20.00

33.33

-421.34

Vitrolife AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
YoY EBITDA Growth	Get a 7-Day Free Trial															-2.48	-8.20	-4,373.44	4.76	20.34

Vitrolife AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vitrolife AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-2.108	-	0.656)	/	\| 0.656 \|
=	-421.34 %

Vitrolife AB's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2024 )
=	(EBITDA per Share (Q: Jun. 2024 )	-	EBITDA per Share (Q: Jun. 2023 ))	/	\| EBITDA per Share (Q: Jun. 2023 )) \|
=	(0.142	-	0.118)	/	\| 0.118 \|
=	20.34 %

Vitrolife AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

VITR:Sweden 0YAY:UK

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB Headlines

No Headlines